We are live on ! Find out more
CCEL icon

Cryo-Cell International

10 hedge funds and large institutions have $7.88M invested in Cryo-Cell International in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

7.7% more ownership

Funds ownership: 0%7.7% (+7.7%)

Holders
10
Holders Change
+10
Holders Change %
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ICM
1
ISZO Capital Management
New York
$6.01M +$6.12M +496,503 New
MPWT
2
MassMutual Private Wealth & Trust
Connecticut
$921K +$937K +76,035 New
SCP
3
Seizert Capital Partners
Michigan
$527K +$536K +43,483 New
MCM
4
Maryland Capital Management
Maryland
$237K +$241K +19,563 New
HighTower Advisors
5
HighTower Advisors
Illinois
$155K +$157K +12,761 New
Bank of America
6
Bank of America
North Carolina
$12K +$12.3K +1,000 New
Morgan Stanley
7
Morgan Stanley
New York
$8K +$8.62K +700 New
Wells Fargo
8
Wells Fargo
California
$6K +$6.16K +500 New
UBS Group
9
UBS Group
Switzerland
$2K +$1.87K +152 New
TRCT
10
Tower Research Capital (TRC)
New York
+$86 +7 New

CCEL Hedge Fund Activity: Q3 2021 in Review

10 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q3 2021, worth a combined $7.88M.

Buyers outnumbered sellers: 10 funds opened new CCEL positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was ISZO Capital Management, opening a new position worth an estimated $6.12M.

  • 10 institutional investors held Cryo-Cell International (CCEL) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $7.88M of Cryo-Cell International stock for Q3 2021.
  • 10 funds opened new Cryo-Cell International positions in Q3 2021 and 0 closed out, a net change of +10 holders.
  • The largest Cryo-Cell International buyer in Q3 2021 was ISZO Capital Management, an estimated $6.12M added.

Based on aggregated 13F filings for Q3 2021.